From Immune Thrombocytopenia to Liver Disease: Expanding Uses of Thrombopoietin Receptor Agonists
The increasing prevalence of thrombocytopenia, rising incidence of immune thrombocytopenia (ITP), aplastic anemia, and chemotherapy-induced thrombocytopenia are driving demand for thrombopoietin receptor agonists worldwide. However, the market also faces several challenges. High treatment costs, stringent regulatory approval requirements, and limited patient access in developing...
0 Commenti 0 condivisioni 4 Views 0 Anteprima
BuzzingAbout https://www.buzzingabout.com